AR100032A1 - Derivados antibacterianos de 1h-indazol y 1h-indol - Google Patents
Derivados antibacterianos de 1h-indazol y 1h-indolInfo
- Publication number
- AR100032A1 AR100032A1 ARP140104742A ARP140104742A AR100032A1 AR 100032 A1 AR100032 A1 AR 100032A1 AR P140104742 A ARP140104742 A AR P140104742A AR P140104742 A ARP140104742 A AR P140104742A AR 100032 A1 AR100032 A1 AR 100032A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxymethyl
- cycloprop
- methyl
- cyclopropyl
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
Reivindicación 1: Un compuesto de fórmula (1) en donde X representa N o CH; R¹ representa H o halógeno; R² representa alquiniloxi C₃₋₄ o el grupo M; R³ representa H o halógeno; M es uno de los grupos de fórmula (2) y (3), en donde A representa un enlace, CH₂CH₂, CH=CH o CºC; R¹A representa H o halógeno; R²A representa H, alcoxi C₁₋₃ o halógeno; R³A representa H, alcoxi C₁₋₃, hidroxialcoxi C₁₋₄, alcoxi C₁₋₃alcoxi C₂₋₃, tioalcoxi C₁₋₃, trifluorometoxi, amino, hidroxialquilo C₁₋₄, 2-hidroxiacetamido, 1-aminociclopropilo, 1-hidroximetil-cicloprop-1-ilo, 1-((fosfonooxi)metil)ciclopropilo, 1-(((dimetilglicil)oxi)metil)ciclopropilo, trans-2-hidroximetil-cicloprop-1-ilo, 1,2-dihidroxietilo, 3-hidroxioxetan-3-ilo, 3-(hidroxialquil C₁₋₃)oxetan-3-ilo, 3-aminooxetan-3-ilo, 3-hidroxitietan-3-ilo, morfolln-4-il-alcoxi C₂₋₃, morfolin-4-il-alquilo C₁₋₂, oxazol-2-ilo o [1,2,3]triazol-2-ilo; y R¹B representa hidroxialquilo C₁₋₃, dihidroxialquilo C₁₋₄, aminoalquilo C₁₋₃, (dimetilamino)metilo, 1-hidroximetil-cicloprop-1-ilo, trans-2-(1,2-dihidroxietil)cicloprop-1-ilo, 1-metil-2-hidroximetil-cicloprop-1-ilo, 2-(hidroximetil)-2-metilciclopropilo, 1-aminometil-cicloprop-1-ilo, trans-2-hidroximetil-cicloprop-1-ilo, 1-fluoro-2-(hidroximetil)ciclopropilo, 2-fluoro-2-(hidroximetil)ciclopropilo, 1-(hidroximetil)ciclobutilo, 3-hidroxioxetan-3-ilo, 3-hidroximetil-oxetan-3-ilo, 3-hidroxitietan-3-ilo, 1-(2-hidroxiacetil)azetidin-3-ilo, 1-(2-aminoacetil)azetidin-3-ilo, 1-glicilazetidin-3-ilo, 1-(2-amino-2-metilpropanoil)azetidin-3-ilo, 3-(2-aminoacetamido)ciclopentilo, trans-(cis-3,4-dihidroxi)-ciclopent-1-ilo, 3-hidroximetilbiciclo[1,1,1]pentan-1-ilo, 3-hidroximetilbiciclo[1,1,1]pentan-1-ilo, piperidin-4-ilo, 1-(2-hidroxiacetil)piperidin-4-ilo, 4-hidroxitetrahidro-2H-piran-4-ilo, 5-aminotetrahidro-2H-piran-2-ilo, (1s,3r)-(1-hidroxi-3-(hidroximetil)ciclobutil)metilo o 3-hidroxioxetan-3-ilmetilo; o una sal de este compuesto.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13198338 | 2013-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR100032A1 true AR100032A1 (es) | 2016-09-07 |
Family
ID=49880464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140104742A AR100032A1 (es) | 2013-12-19 | 2014-12-18 | Derivados antibacterianos de 1h-indazol y 1h-indol |
Country Status (22)
Country | Link |
---|---|
US (1) | US9624206B2 (es) |
EP (1) | EP3083567B1 (es) |
JP (1) | JP6407288B2 (es) |
KR (1) | KR20160098503A (es) |
CN (1) | CN105829288B (es) |
AR (1) | AR100032A1 (es) |
AU (1) | AU2014368619B2 (es) |
BR (1) | BR112016014115A8 (es) |
CA (1) | CA2933604A1 (es) |
CL (1) | CL2016001524A1 (es) |
EA (1) | EA030730B1 (es) |
ES (1) | ES2666130T3 (es) |
IL (1) | IL246201A0 (es) |
MA (1) | MA39189A1 (es) |
MX (1) | MX360983B (es) |
PH (1) | PH12016501102A1 (es) |
PL (1) | PL3083567T3 (es) |
SG (1) | SG11201605014YA (es) |
TR (1) | TR201807881T4 (es) |
TW (1) | TW201609641A (es) |
WO (1) | WO2015091741A1 (es) |
ZA (1) | ZA201604968B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR097617A1 (es) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
JP2017515906A (ja) | 2014-05-16 | 2017-06-15 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | 抗菌性キナゾロン−4(3h)−オン誘導体 |
BR112017010474A2 (pt) | 2014-11-19 | 2017-12-26 | Actelion Pharmaceuticals Ltd | derivados antibacterianos de benzotiazol |
AR105646A1 (es) | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
MA42679A (fr) * | 2015-08-28 | 2018-07-04 | Idorsia Pharmaceuticals Ltd | Dérivés de pyrrolidin-2-one annelés antibactériens |
AR105848A1 (es) * | 2015-08-31 | 2017-11-15 | Actelion Pharmaceuticals Ltd | Derivados heterocíclicos antibacterianos |
AR105889A1 (es) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
BR112018073580A2 (pt) * | 2016-05-17 | 2019-03-19 | Idorsia Pharmaceuticals Ltd | derivados de 6-(buta-1,3-diyn-1-il) benzo [d] tiazol |
WO2018216822A1 (en) | 2017-05-25 | 2018-11-29 | Taisho Pharmaceutical Co., Ltd. | Novel imidazole derivatives |
WO2019086452A1 (en) * | 2017-10-31 | 2019-05-09 | Idorsia Pharmaceuticals Ltd | Antibacterial heteroaromatic compounds |
CN113666860B (zh) * | 2020-05-14 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种7-乙基色醇的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ535158A (en) | 2002-03-13 | 2007-06-29 | Array Biopharma Inc | N3 alkylated benzimidazole derivatives as MEK inhibitors |
DE102004017930A1 (de) | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
EA012181B1 (ru) | 2004-10-18 | 2009-08-28 | Амген, Инк. | Соединения тиадиазола и их применение |
BRPI0609719B8 (pt) | 2005-03-23 | 2021-05-25 | Hoffmann La Roche | derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2 |
JP5539864B2 (ja) | 2007-06-12 | 2014-07-02 | アカオゲン,インコーポレーテッド | 抗菌剤 |
WO2010135536A2 (en) | 2009-05-20 | 2010-11-25 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
JP5671545B2 (ja) * | 2009-10-13 | 2015-02-18 | ファイザー・インク | 抗菌薬として有用なc結合ヒドロキサム酸誘導体 |
SI2512474T1 (sl) | 2009-12-16 | 2014-12-31 | Pfizer Inc. | N-vezani derivati hidroksamske kisline, uporabni kot protibakterijska sredstva |
GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
EP2638006A1 (en) | 2010-11-10 | 2013-09-18 | Achaogen, Inc. | Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
US8853213B2 (en) | 2011-01-03 | 2014-10-07 | Hanmi Pharm. Co., Ltd | Bicyclic compound for modulating G protein-coupled receptors |
SG192766A1 (en) * | 2011-03-07 | 2013-09-30 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
CN103717582B (zh) | 2011-04-08 | 2015-09-30 | 辉瑞大药厂 | 用作抗菌剂的异*唑衍生物 |
MX2013011432A (es) | 2011-04-08 | 2013-12-09 | Pfizer | Derivados de imidazol, pirazol, y triazol utiles como agentes antibacterianos. |
EP2847162A1 (en) | 2012-05-09 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
WO2013170165A1 (en) | 2012-05-10 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
AR097617A1 (es) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
JP2017515906A (ja) | 2014-05-16 | 2017-06-15 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | 抗菌性キナゾロン−4(3h)−オン誘導体 |
-
2014
- 2014-12-18 US US15/106,790 patent/US9624206B2/en active Active
- 2014-12-18 TR TR2018/07881T patent/TR201807881T4/tr unknown
- 2014-12-18 KR KR1020167019669A patent/KR20160098503A/ko not_active Application Discontinuation
- 2014-12-18 CA CA2933604A patent/CA2933604A1/en not_active Abandoned
- 2014-12-18 TW TW103144395A patent/TW201609641A/zh unknown
- 2014-12-18 PL PL14812752T patent/PL3083567T3/pl unknown
- 2014-12-18 JP JP2016541300A patent/JP6407288B2/ja not_active Expired - Fee Related
- 2014-12-18 EA EA201600475A patent/EA030730B1/ru not_active IP Right Cessation
- 2014-12-18 CN CN201480067976.9A patent/CN105829288B/zh not_active Expired - Fee Related
- 2014-12-18 BR BR112016014115A patent/BR112016014115A8/pt not_active Application Discontinuation
- 2014-12-18 ES ES14812752.5T patent/ES2666130T3/es active Active
- 2014-12-18 SG SG11201605014YA patent/SG11201605014YA/en unknown
- 2014-12-18 MX MX2016007991A patent/MX360983B/es active IP Right Grant
- 2014-12-18 EP EP14812752.5A patent/EP3083567B1/en not_active Not-in-force
- 2014-12-18 AR ARP140104742A patent/AR100032A1/es unknown
- 2014-12-18 MA MA39189A patent/MA39189A1/fr unknown
- 2014-12-18 AU AU2014368619A patent/AU2014368619B2/en not_active Ceased
- 2014-12-18 WO PCT/EP2014/078384 patent/WO2015091741A1/en active Application Filing
-
2016
- 2016-06-09 PH PH12016501102A patent/PH12016501102A1/en unknown
- 2016-06-14 IL IL246201A patent/IL246201A0/en unknown
- 2016-06-16 CL CL2016001524A patent/CL2016001524A1/es unknown
- 2016-07-18 ZA ZA2016/04968A patent/ZA201604968B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN105829288A (zh) | 2016-08-03 |
EA030730B1 (ru) | 2018-09-28 |
WO2015091741A1 (en) | 2015-06-25 |
JP6407288B2 (ja) | 2018-10-17 |
CL2016001524A1 (es) | 2017-01-27 |
ES2666130T3 (es) | 2018-05-03 |
AU2014368619B2 (en) | 2018-11-22 |
BR112016014115A8 (pt) | 2017-12-26 |
MA39189A1 (fr) | 2017-06-30 |
KR20160098503A (ko) | 2016-08-18 |
CN105829288B (zh) | 2019-01-15 |
EP3083567A1 (en) | 2016-10-26 |
BR112016014115A2 (es) | 2017-08-08 |
TR201807881T4 (tr) | 2018-06-21 |
EP3083567B1 (en) | 2018-03-07 |
MX360983B (es) | 2018-11-22 |
EA201600475A1 (ru) | 2016-11-30 |
SG11201605014YA (en) | 2016-07-28 |
ZA201604968B (en) | 2018-11-28 |
IL246201A0 (en) | 2016-08-02 |
AU2014368619A1 (en) | 2016-07-28 |
TW201609641A (zh) | 2016-03-16 |
US20170029411A1 (en) | 2017-02-02 |
US9624206B2 (en) | 2017-04-18 |
JP2017500336A (ja) | 2017-01-05 |
PL3083567T3 (pl) | 2018-08-31 |
PH12016501102A1 (en) | 2016-07-11 |
MX2016007991A (es) | 2016-10-07 |
CA2933604A1 (en) | 2015-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR100032A1 (es) | Derivados antibacterianos de 1h-indazol y 1h-indol | |
AR097617A1 (es) | Derivados antibacterianos del 2h-indazol | |
AR099612A1 (es) | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona | |
AR100428A1 (es) | Derivados antibacterianos quinazolina-4(3h)-ona | |
AR108745A1 (es) | Derivados de oxadiazol microbiocidas | |
AR100033A1 (es) | Compuestos y composiciones para inhibir la actividad de shp2 | |
AR094667A1 (es) | Piridonamidas como moduladores de canales de sodio | |
AR100137A1 (es) | Compuestos 4-amino-imidazoquinolina | |
AR094309A1 (es) | Compuesto heterociclico fusionado y uso del mismo para el control de plagas | |
AR090328A1 (es) | Pirrolidina-2-carboxamidas sustituidas | |
AR102687A1 (es) | Derivados de benzotiazol antibacterianos | |
AR118706A2 (es) | Compuesto para el control de plagas y vegetación no deseada, procedimiento para prepararlo, composición que lo comprende, y compuesto intermediario relacionado | |
AR094537A1 (es) | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa | |
AR082138A1 (es) | 1-hidroxiimino-3-fenil-propanos | |
EA201591486A1 (ru) | Соединения имидазопиридина | |
ES2531315T3 (es) | Compuestos de fosfinato antivíricos | |
MX2010002272A (es) | 4-(4-piridinil)-benzamidas y su uso como moduladores de la actividad de rho-cinasa (rock). | |
AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
AR074021A1 (es) | Compuestos heterociclicos fusionados como moduladores del canal ionico | |
AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
AR090939A1 (es) | Sales de amidas de los acidos n-(tetrazol-5-il)- y n-(triazol-5-il)arilcarboxilicos y su uso como herbicidas | |
AR097082A1 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
CY1120680T1 (el) | Ανταγωνιστες η3 που περιεχουν συνταξη πυρηνα φαινοξυπιπεριδινης | |
AR098871A1 (es) | Métodos de proceso para inhibidores de fosfatidilinositol 3-quinasa | |
AR093143A1 (es) | Compuestos de 2-aminopiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |